(Q48895239)

16 February 2018

title

Decreased mesopontine choline acetyltransferase levels in schizophrenia. Correlations with cognitive functions. (English)

1 reference

16 February 2018

0 references

C N Karson

1

1 reference

16 February 2018

R E Mrak

series ordinal

2

1 reference

16 February 2018

M M Husain

series ordinal

3

1 reference

16 February 2018

W S Griffin

series ordinal

4

1 reference

16 February 2018

publication date

1 October 1996

1 reference

16 February 2018

Molecular and Chemical Neuropathology

published in

1 reference

16 February 2018

volume

29

1 reference

16 February 2018

issue

2-3

1 reference

16 February 2018

page(s)

181-191

1 reference

16 February 2018

The nucleus basalis of Meynert, senile plaques, and intellectual impairment in schizophrenia

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02815001

Diagnostic Criteria for Use in Psychiatric Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02815001

Provocation of Schizophrenic Symptoms by Intravenous Administration of Methylphenidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02815001

Antagonistic Effects of Physostigmine and Methylphenidate in Man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02815001

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02815001

Cholinergic hyperactivity and negative schizophrenic symptoms. A model of cholinergic/dopaminergic interactions in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02815001

21 January 2018

Identifiers

DOI

10.1007/BF02815001

1 reference

16 February 2018

1 reference

16 February 2018